A PHP Error was encountered
Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionqlv4o2api4ifrgis83o2h7e4dpfo704d): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
A PHP Error was encountered
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Similar Publications
Fibroadenoma presenting in the axilla is a rare occurrence often associated with ectopic breast tissue. Accessory breast(s) are characterized by the existence of additional breasts, exceeding the typical count of two, accompanied by or without a nipple and areola, in human anatomy. It can manifest at any point along the primitive embryonic milk lines, which extend from the armpit to the groin region.
View Article and Find Full Text PDF
Ewing sarcoma family tumors (ESFT) pose diagnostic challenges, which largely depend on the primary site of involvement and tumor stage. Despite advancements in treatment, metastatic ESFTs remain associated with poor outcomes. This case describes a 21-year-old woman who, in July 2022, presented with a left breast mass identified through ultrasound and CT scan, along with abdominal distention.
View Article and Find Full Text PDF
Diagnostics (Basel)
November 2024
Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 15772 Athens, Greece.
Ewing sarcomas are rare tumors arising mainly in the bones and the surrounding soft tissues. Primary extraosseous Ewing sarcomas have also been described in several other organs and locations other than bones, including the pancreas. These tumors have well-defined histological, immunohistochemical, and molecular characteristics.
View Article and Find Full Text PDF
Eur J Surg Oncol
December 2024
Humanitas Istituto Clinico Catanese, Misterbianco, Catania, Italy; G.Re.T.A. Group for Reconstructive and Therapeutic Advancements Fondazione ETS, Naples, Italy.
Introduction: Neoadjuvant therapy (NAT) should increase the rate of breast-conserving surgery (BCS) in non-metastatic breast cancer (BC) patients, especially in those achieving tumor shrinkage. Still, the conversion from a pre-planned mastectomy to BCS in patients responding to NAT is not a widespread standard. We aimed to identify factors influencing surgical choices in this setting.
View Article and Find Full Text PDF
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
